Journal profile · Biochemistry & Molecular Biology
Journal of Liposome Research
ISSN 0898-2104 · eISSN 1532-2394 · Taylor & Francis · UNITED STATES · Quarterly · Founded 1988
Journal of Liposome Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.91; subscription journal; median 93 days to acceptance (95 articles, last 24 months); community-reported acceptance: fairly easy; 49 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Liposome Research is published by Taylor & Francis and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Lipid Membrane Structure and Behavior and RNA Interference and Gene Delivery, together about 47.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Liposome Research aims to publish original, high-quality, peer-reviewed research on the topic of liposomes and related systems, lipid-based delivery systems, lipid biology, and both synthetic and physical lipid chemistry. Reviews and commentaries or editorials are generally solicited and are editorially reviewed. The Journal also publishes abstracts and conference proceedings including those from the International Liposome Society. The scope of the Journal includes: Formulation and characterisation of systems Formulation engineering of systems Synthetic and physical lipid chemistry Lipid Biology Biomembranes Vaccines Emerging technologies and systems related to liposomes and vesicle type systems Developmental methodologies and new analytical techniques pertaining to the general area Pharmacokinetics, pharmacodynamics and biodistribution of systems Clinical applications. The Journal also publishes Special Issues focusing on particular topics and themes within the general scope of the Journal.
Source: LetPub
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoparticle-Based Drug DeliveryMaterials Science16.6%
- Lipid Membrane Structure and BehaviorBiochemistry, Genetics and Molecular Biology15.9%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology14.9%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics9.4%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.6%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology5.5%
- Immunotherapy and Immune ResponsesImmunology and Microbiology2.8%
- Surfactants and Colloidal SystemsChemistry2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.91LetPub ·
- CiteScore 2026-06
- 8.3LetPub ·
- SJR 2026-06
- 0.7LetPub ·
- SNIP 2026-06
- 0.91LetPub ·
- h-index
- 44LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 782OpenAlex ·
- 2-year mean citedness
- 3.83OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 4.07%LetPub ·
Volume
- Articles per year
- 46LetPub ·
Articles by year OpenAlex count · 1,386 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 43 | 8 | 23 |
| 2025 | 49 | 8 | 160 |
| 2024 | 33 | 7 | 296 |
| 2023 | 45 | 7 | 666 |
| 2022 | 28 | 5 | 470 |
| 2021 | 23 | 5 | 486 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
93 daysMedian, submission to acceptance · P25–P75 59 days – 124 days
- Acceptance to online
- median 14 days (95 articles)
- Submission to online
- median 111 days
- Sample
- 95 articles with submission and acceptance dates (96 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1988
- ISSN
- 0898-2104
- Electronic ISSN
- 1532-2394
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Liposome Research
What CAS zone is Journal of Liposome Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Liposome Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Liposome Research?
The latest impact factor listed by LetPub is 4.91; CiteScore 8.3, h-index 80.
How long does peer review take at Journal of Liposome Research?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 59–124 days); authors report an average review time of about 3 months; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Liposome Research?
According to LetPub and DOAJ records, Journal of Liposome Research is indexed in SCIE and Scopus.
Is Journal of Liposome Research open access, and what is the APC?
Journal of Liposome Research is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .